Literature DB >> 23772062

Long-lasting attenuation of amygdala-kindled seizures after convection-enhanced delivery of botulinum neurotoxins a and B into the amygdala in rats.

Maciej Gasior1, Rebecca Tang, Michael A Rogawski.   

Abstract

Botulinum neurotoxins (BoNTs) are well recognized to cause potent, selective, and long-lasting neuroparalytic actions by blocking cholinergic neurotransmission to muscles and glands. There is evidence that BoNT isoforms can also inhibit neurotransmission in the brain. In this study, we examined whether locally delivered BoNT/A and BoNT/B can attenuate kindling measures in amygdala-kindled rats. Male rats were implanted with a combination infusion cannula-stimulating electrode assembly into the right basolateral amygdala. Fully kindled animals received a single infusion of vehicle or BoNT/A or BoNT/B at doses of 1, 3.2, or 10 ng over a 20-minute period by convection-enhanced delivery. Electrographic (EEG) and behavioral kindling measures were determined at selected times during the 3- to 64-day period after the infusion. BoNT/B produced a dose-dependent elevation in after-discharge threshold and duration and a reduction in the seizure stage and duration of behavioral seizures that lasted for up to 50 days after infusion. BoNT/A had similar effects on EEG measures; behavioral seizure measures were also reduced, but the effect did not reach statistical significance. The effects of both toxins on EEG and behavioral measures progressively resolved during the latter half of the observation period. Animals gained weight normally, maintained normal body temperature, and did not show altered behavior. This study demonstrates for the first time that locally delivered BoNTs can produce prolonged inhibition of brain excitability, indicating that they could be useful for the treatment of brain disorders, including epilepsy, that would benefit from long-lasting suppression of neurotransmission within a circumscribed brain region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23772062      PMCID: PMC3876783          DOI: 10.1124/jpet.113.205070

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.

Authors:  Timothy Corcoran Flynn; Robert E Clark
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

Review 2.  New routes for delivery of anti-epileptic medications.

Authors:  Robert S Fisher; David K Chen
Journal:  Acta Neurol Taiwan       Date:  2006-12

3.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.

Authors:  Jiafu Wang; Tomas H Zurawski; Jianghui Meng; Gary Lawrence; Weredeselam M Olango; David P Finn; Larry Wheeler; J Oliver Dolly
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

6.  Interictal and ictal activity in the rat cobalt/pilocarpine model of epilepsy decreased by local perfusion of diazepam.

Authors:  H G Eder; A Stein; R S Fisher
Journal:  Epilepsy Res       Date:  1997-12       Impact factor: 3.045

Review 7.  Focal treatment for refractory epilepsy: hope for the future?

Authors:  Karen E Nilsen; Hannah R Cock
Journal:  Brain Res Brain Res Rev       Date:  2004-03

8.  Central injection of botulinum neurotoxins: behavioural effects in mice.

Authors:  S Luvisetto; S Marinelli; O Rossetto; C Montecucco; F Pavone
Journal:  Behav Pharmacol       Date:  2004-05       Impact factor: 2.293

9.  Toxicity of botulinum neurotoxins in central nervous system of mice.

Authors:  Siro Luvisetto; Ornella Rossetto; Cesare Montecucco; Flaminia Pavone
Journal:  Toxicon       Date:  2003-03       Impact factor: 3.033

10.  Traffic of botulinum toxins A and E in excitatory and inhibitory neurons.

Authors:  Claudia Verderio; Carlotta Grumelli; Luca Raiteri; Silvia Coco; Silvio Paluzzi; Paola Caccin; Ornella Rossetto; Giambattista Bonanno; Cesare Montecucco; Michela Matteoli
Journal:  Traffic       Date:  2007-02       Impact factor: 6.215

View more
  10 in total

1.  Convection-enhanced delivery of botulinum toxin serotype A into the nonhuman primate cisterna magna and hippocampus.

Authors:  Davis P Argersinger; Stuart Walbridge; Nicholas M Wetjen; Alexander O Vortmeyer; Tianxia Wu; John A Butman; John D Heiss
Journal:  J Neurosurg       Date:  2019-07-19       Impact factor: 5.115

2.  Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.

Authors:  S Bröer; D Zolkowska; M Gernert; M A Rogawski
Journal:  Neuroscience       Date:  2013-07-29       Impact factor: 3.590

3.  Intranasal Delivery of Botulinum Neurotoxin A Protects against Hippocampal Neuron Death in the Lithium-Pilocarpine Rat Model.

Authors:  Zhi Huang; Yajun Lian; Yuan Chen; Shuang Li; Haifeng Zhang; Nanchang Xie; Yake Zheng; Shouyi Wu; Yuhan Wang; Wenchao Cheng; Qiaoman Zhang; Chengze Wang; Yinping Shi; Na Xie
Journal:  Neurochem Res       Date:  2019-03-14       Impact factor: 3.996

Review 4.  Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review.

Authors:  Alexander Hawlitschka; Andreas Wree
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

Review 5.  Bypassing the Blood-Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies.

Authors:  Manuela Gernert; Malte Feja
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

Review 6.  Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy.

Authors:  Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2021-10-22       Impact factor: 4.546

Review 7.  Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology.

Authors:  Matteo Caleo; Laura Restani
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

8.  Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats.

Authors:  Veronica Antipova; Andreas Wree; Carsten Holzmann; Teresa Mann; Nicola Palomero-Gallagher; Karl Zilles; Oliver Schmitt; Alexander Hawlitschka
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

9.  The Impacts of Surgery and Intracerebral Electrodes in C57BL/6J Mouse Kainate Model of Epileptogenesis: Seizure Threshold, Proteomics, and Cytokine Profiles.

Authors:  Karen Tse; Edward Beamer; Deborah Simpson; Robert J Beynon; Graeme J Sills; Thimmasettappa Thippeswamy
Journal:  Front Neurol       Date:  2021-07-12       Impact factor: 4.003

10.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.